New York, NY · Founded 2019 · Privately Held (backing)
Developer of an ECG (Electrocardiogram)-based diagnostics software platform intended to enhance interpretation of electrocardiogram data for improved detection of cardiovascular and metabolic… AccurKardia is based in New York, NY and was founded in 2019. It has raised $9 million across 1 recorded round; the latest was a $4.1 million seed round in Aug 2022.
3 investors are on record for AccurKardia, including MedTech Innovator, Mayo Clinic Platform and Popular. The seed round in Aug 2022 drew 41 investors.
Free account
More of AccurKardia with a free account
·Watch AccurKardia: the Monday email on marks, rounds and moves
These 3 firms already write checks for companies like AccurKardia. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.